valspodar: Clinical Trials

4 trials of valspodar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow valspodar: new trials by email Literature Review of valspodar trials Research Report on valspodar

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
filgrastim, sargramostim, cytarabine - Leukemia
Phase 2CompletedSWOG Cancer Research Network552000-02-012015-03-06
Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
paclitaxel, valspodar - Breast Cancer
Phase 2CompletedEastern Cooperative Oncology Group361997-08-142023-06-07
Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
ara-C, Daunorubicin, Etoposide - Leukemia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)4101997-02-012012-11-30
Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
paclitaxel, valspodar - Breast Cancer
Phase 2CompletedCity of Hope Medical Center701996-06-012010-01-06

Conditions studied

Breast Neoplasms (2)  ·  Leukemia (2)  ·  Leukemia, Erythroblastic, Acute (2)  ·  Leukemia, Megakaryoblastic, Acute (2)  ·  Leukemia, Monocytic, Acute (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myelomonocytic, Acute (2)

Sponsors

City of Hope Medical Center (1)  ·  Eastern Cooperative Oncology Group (1)  ·  National Cancer Institute (NCI) (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (4)  ·  Canada (2)

Top investigators

James H. Doroshow, MD (1)  ·  Jonathan E. Kolitz, MD (1)  ·  Robert W. Carlson, MD (1)  ·  Thomas R. Chauncey, MD, PhD (1)

Results publications

PMID 11331327, PMID 11585760, PMID 12750167, PMID 15514371, PMID 16275934, PMID 16670265, PMID 24383844, PMID 25527568

NIH funding

U01CA063265 (1), U10CA031946 (1), U10CA032102 (1)